Cardiovascular Benefits of Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Patients Achieving Tight Blood Pressure Control and With Resistant Hypertension.
Robert D BrookNiko KacirotiGeorge BakrisBjörn DahlöfBertrtam PittEric VelazquezMichael A WeberKenneth A JamersonPublished in: American journal of hypertension (2021)
Trial Number NCT00170950.
Keyphrases
- blood pressure
- angiotensin converting enzyme
- end stage renal disease
- ejection fraction
- angiotensin ii
- newly diagnosed
- chronic kidney disease
- prognostic factors
- blood brain barrier
- heart rate
- peritoneal dialysis
- study protocol
- randomized controlled trial
- hypertensive patients
- type diabetes
- adipose tissue
- skeletal muscle
- insulin resistance
- open label